Cellular Dynamics Inks Supply Deal with Nestle | GenomeWeb

NEW YORK (GenomeWeb News) – Cellular Dynamics International today said that it has signed a deal to supply the Nestlé Institute of Health Sciences with its iCell and MyCell product lines.

The iCell portfolio includes cardiomyocytes, neurons, hepatocytes, endothelial cells, and other cell types in development, while the MyCell line includes cell products manufactured from donor samples using iPSC technology to make stem cells or differentiated cells from any individual.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: adzuki bean genome, spontaneous mutation patterns in E. coli, and more.

An op-ed in the New York Times discusses banking of fecal samples to restore the gut microbiome.

Rules and regulations governing genetic modifications of human embryos vary from country to country, Nature News says, but such work may take place despite restrictions.

Ancestry.com is eyeing an expansion into genomic risk assessments, the Verge reports.